combined with in-feed anticoccidial drugs or vaccination with live parasites. However, 23 outbreaks of coccidiosis still occur and sub-clinical infections, which impact significantly on 24 productivity and food security, are common due to widespread drug resistance, high parasite 25 prevalence, and environmental persistence. Herein, we review some recent approaches for 26 the production of cheaper third generation vaccines, based on robust methods for 27 identification of immunoprotective antigens and the use of transgenic Eimeria. 
Current options for control 82
Successful commercialisation of poultry production in housed, free-range, and organic 83 systems relies on effective control of Eimeria parasites. Good husbandry plays a key role in 84 limiting oocyst sporulation and recycling through measures such as restricting bird access to 85 faeces, maintaining litter quality, controlling house temperature, ventilation, and moisture 86 levels, and thorough cleaning between flocks. However, husbandry alone is inadequate for 87 control, and prophylactic anticoccidial drugs (ionophores and other chemicals) are crucial for 88 sustainability of most production systems. In the UK more than 40% of all antimicrobials 89 sold for use in food and non-food animals are classified for the control of coccidial parasites 90 (277 tonnes of active ingredient in 2011; mostly for control of Eimeria) with ionophores 91 representing more than 70% of these [15] . Resistance to anticoccidial drugs has been 92 recognized for decades and regarded as ubiquitous [16] with wide acceptance that drugs 93 remain effective in the field only because they suppress parasite growth sufficiently to allow 94 birds to develop natural immunity [17] . The speed at which resistance can appear, combined 95 with legislative restrictions on the use of many in-feed drugs in some countries and 96 consumer concerns regarding chemical residues in food products has discouraged most 97 attempts to develop new anticoccidials. 98
99
The major alternative option for coccidiosis control is vaccination, which is used effectively to 100 protect egg-laying and breeder chickens but applied more rarely within the majority broiler 101 attenuated vaccines. Most of these vaccines contain parasites derived by selection for the 120 trait of "precocious" development (i.e., more rapid completion of the life cycle with a reduced 121 pre-patent period, lower reproductive capacity and consequential reduction in pathogenicity). while partially protective effects have been reported in many of these experimental challenge 185 studies, progress towards vaccine commercialization has not followed for any of them. candidates. Building on previous observations that strain-specific immune selection of 238 genetically distinct E. maxima strains conferred a highly selectable phenotype [66] , genomic 239 regions whose inheritance conferred susceptibility to immune selection were mapped using 240 a 'hitch-hiker' mapping strategy ( 
Concluding remarks 331
Coccidiosis caused by parasitic Eimeria species remains one of the greatest burdens on the 332 economics of production of poultry and poultry-derived products. While control is widely 333 available through the use of anticoccidial drugs, and live first and second-generation 334 vaccines, neither of these are completely satisfactory, and new strategies are urgently 335 required. A third generation of more cost-effective anticoccidial vaccines seems to be 336 feasible with several candidate antigens described and many reports of partial protection in 337 experimental settings. However, none of these approaches has progressed into commercial 338 development despite more than 25 years of research [ Eimeria tenella sporozoite antigen in birds. forms a resistant wall as it transforms into an oocyst which escapes from the host cell into 583 the intestinal lumen to be excreted into the environment to initiate the exogenous phase. 9. 584
The unsporulated (non-infectious) oocyst undergoes sporulation in the environment requiring 585 warmth, oxygen and moisture as it undergoes sequential meiotic and mitotic nuclear division 586 to become a sporulated oocyst. The sporulated oocyst, which contains four sporocysts, each 587 of which contain two sporozoites, is now infectious. 588
Each stage of the Eimeria life cycle within the host is known to be immunogenic, with 589 the early life cycle stages considered to be most important in the induction of a protective 590 immune response [33, 93, 94] . Few of the current anticoccidial vaccine candidates are 591 expressed throughout the Eimeria life cycle and it is likely that multiple antigens will be 592 required if an effective subunit vaccine is to be established. The identification of optimal delivery mechanisms and adjuvants will be crucial. 
formulation. 636
Abbreviations: , tested and found to be effective; n/d, not determined. 637 638
